A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations - Concepedia

Concepedia

Publication | Closed Access

A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations

47

Citations

46

References

2012

Year

Sayaka Fukuda-Tsuru, Jun Anabuki, Yuji Abe, Kumiko Yoshida, Shin‐ichi Ishii

European Journal of Pharmacology

Metabolic SyndromeDiabetes ManagementBiochemistryDiabetesPharmacologyHyperlipidemiaPharmacotherapyMedicineAtherosclerosisDyslipidemiaDrug DiscoveryPostprandial Hyperglycemia

References

	Year	Citations

Page 1